Fri, Dec 26, 2014, 2:46 PM EST - U.S. Markets close in 1 hr 14 mins


% | $
Quotes you view appear here for quick access.

ImmunoGen, Inc. Message Board

  • nebraskatom01 nebraskatom01 Jan 8, 2013 10:40 AM Flag

    Take off !

    Passing 200 day/100 day and 50 day is usually a bullish signal(today)........with TDM1 approval pending and minimal resistance all the way to 16 we should do well for near term.......IMO Strong buy!

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • technically, IMGN's a little extended here, I would consider put sales as a lower-risk, lower cost way to enter for defensive investors. On the other hand, IMGN traded $18 last year and approval seems close. Thanks for the MA cross info, keep an eye on the option vol.

      • 1 Reply to bioimmunomabman
      • Some some tweets from Conference that many believe the delay on approval is over labeling. If Roche is able to negotiate a broader label, analyst will have to revalue IMGN. I see IMGN as a patent extension play for all MAB oncology drugs. Lot's of intrinsic value here that will soon be recognized. IMGN is also a scarcity value in pure MAB market. I'm long after this last UBS short call. This is the transformation from R&D to commercialization long term rise. Don't be left out as an acquisition can occur anytime after first 2 -3 quarters of TDM1 sales. Will be de-risked on approval!

        Sentiment: Strong Buy

5.9601+0.0601(+1.02%)2:44 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.